Preterm birth and fetal growth restriction in HIV-infected Brazilian pregnant women;Nascimento pré-termo e restrição de crescimento fetal em gestantes brasileiras infectadas pelo HIV

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 57, Issue 2, 2015, Pages 111-120

  dos Reis, Helena Lucia Barroso ^a   Araujo, Karina da Silva ^a   Ribeiro, Lilian Paula ^a   da Rocha, Daniel Ribeiro ^a   Rosato, Drielli Petri ^a   Passos, Mauro Romero Leal ^b   Merçon de Vargas, Paulo Roberto ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Fetal weight; HIV; Infant; Low birth weight; Pregnancy; Preterm birth; Small for gestational age

Indexed keywords

ABDOMINAL CIRCUMFERENCE; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; BRAZIL; COMPLICATION; FETAL GROWTH RETARDATION; HIV INFECTIONS; LOW BIRTH WEIGHT; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVALENCE; RISK FACTOR; SOCIOECONOMICS;

ADULT; BRAZIL; FEMALE; FETAL GROWTH RETARDATION; HIV INFECTIONS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84928744762     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652015000200003     Document Type: Article

References (59)

1. Aaron E, Bonacquisti A, Mathew L, Alleyne G, Bamford LP, Culhane JF. Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:135030.
2. Banda Y, Chapman V, Goldenberg RL, Chi BH, Vermund SH, Stringer JS. Influence of body mass index on pregnancy outcomes among HIV-infected and HIV-uninfected Zambian women. Trop Med Int Health. 2007;12:856-61.
3. Barker DJ. The developmental origins of adult disease. Eur J Epidemiol. 2003;18:733-6.
4. Baroncelli S, Tamburrini E, Ravizza M, Pinnetti C, Dalzero S, Scatà M, et al. Pregnancy outcomes in women with advanced HIV infection in Italy. AIDS Patient Care STDS. 2011;25:639-45.
5. Barros FC, Victora CG, Matijasevich A, Santos IS, Horta BL, Silveira MF. Preterm births, low birth weight, and intrauterine growth restriction in three birth cohorts in Southern Brazil: 1982, 1993 and 2004. Cad Saude Publica. 2008;24(Suppl 3):S390-8.
6. Belizán JM, Lechtig A, Villar J. Distribution of low-birth weight babies in developing countries. Am J Obstet Gynecol. 1978;132:704-5.
7. Bernstein IM, Mohs G, Rucquoi M, Badger GJ. Case for hybrid “fetal growth curves”: a population-based estimation of normal fetal size across gestational age. J Matern Fetal Med. 1996;5:124-7.
8. Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodríguez D, Smith L. Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. Obstet Gynecol. 2010;115:1247-55.
9. Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG. 2007;114:148-55.
10. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Banco de dados do Sistema de Informações sobre Nascidos Vivos (SINASC), 1994 a 2010. Brasília: MS/SVS; 2011.
11. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guia de vigilância epidemiológica. 7a ed. Brasília: Ministério da Saúde; 2009.
12. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Recomendações para profilaxia da transmissão vertical do HIV e terapia anti-retroviral em gestantes. Brasília: Ministério da Saúde; 2010.
13. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:836-48.
14. Cameron N, Preece MA, Cole TJ. Catch-up growth or regression to the mean? Recovery from stunting revisited. Am J Hum Biol. 2005;17:412-7.
15. Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 2. Head measurements. Br J Obstet Gynaecol. 1994;101:35-43.
16. Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 3. Abdominal measurements. Br J Obstet Gynaecol. 1994;101:125-31.
17. Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 4. Femur length. Br J Obstet Gynaecol. 1994;101:132-5.
18. Costello A, Francis V, Byrne A, Puddephatt C. Saving newborn lives: state of the world’s newborns. Washington: Save the Children and Women & Children First; 2001.
19. Cotter AM, Garcia AG, Duthely ML, Luke B, O’Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis. 2006;193:1195-201.
20. Deter RL, Nazar R, Milner LL. Modified neonatal growth assessment score: a multivariate approach to the detection of intrauterine growth retardation in the neonate. Ultrasound Obstet Gynecol. 1995;6:400-10.
21. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr. 200;74:814-26.
22. Euser AM, de Wit CC, Finken MJ, Rijken M, Wit JM. Growth of preterm born children. Horm Res. 2008;70:319-28.
23. Fausto MA, Carneiro II M, Antunes CMF, Colosimo EA, Pinto JA. Longitudinal anthropometric assessment of infants born to HIV-1 infected mother, Belo Horizonte, Southeastern Brazil. Rev Saude Publica. 2011;45:652-60.
24. Feinstein AR. Principles of medical statistics. London: Chapman Hall; 2002.
25. Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6:168-74.
26. Gardosi J. Customized fetal growth standards: rationale and clinical application. Semin Perinatol. 2004;28:33-40.
27. Gardosi J, Figueras F, Clausson B, Francis A. The customised growth potential: an international research tool to study the epidemiology of fetal growth. Paediatr Perinat Epidemiol. 2011;25:2-10.
28. Genest DR, Williams MA, Greene MF. Estimating the time of death in stillborn fetuses: I. Histologic evaluation of fetal organs; an autopsy study of 150 stillborns. Obstet Gynecol. 1992;80:575-84.
29. Habib NA, Daltveit AK, Bergsjø P, Shao J, Oneko O, Lie RT. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG. 2008;115:616-24.
30. Hadlock FP, Deter RL, Roecker E, Harrist RB, Park SK. Relation of fetal femur length to neonatal crown-heel length. J Ultrasound Med. 1984;3:1-3.
31. Hoaglin DC, Mosteler F, Tukey JW. Understanding robust and exploratory data analysis. New York: Willey; 2000.
32. Hutcheon JA, Platt RW. The missing data problem in birth weight percentiles and thresholds for “small-for-gestational-age”. Am J Epidemiol. 2008;167:786-92.
33. Kim HY, Kasonde P, Mwiya M, Thea DM, Kankasa C, Sinkala M, et al. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr. 2012;12:138.
34. Kramer MS, Demissie K, Yang H, Platt RW, Sauvé R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. JAMA. 2000;284:843-9.
35. Lawn JE, Cousens SN, Darmstadt GL, Bhutta ZA, Martines J, Paul V, et al. 1 year after The Lancet Neonatal Survival Series--was the call for action heard? Lancet. 2006;367(9521):1541-7.
36. Machado ES, Hofer CB, Costa TT, Nogueira SA, Oliveira RH, Abreu TF, et al. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm Infect. 2009;85:82-7.
37. Melo VH, Aguiar RALP, Lobato ACL, Cavallo IKD, Kakehasi, FM, Romanelli, RMC, et al. Resultados maternos e perinatais de dez anos de assistência obstétrica a portadoras do vírus da imunodeficiência humana. Rev Bras Ginecol Obstet. 2005;27:683-90.
38. Menezes Succi RC. Mother-to-child transmission of HIV in Brazil during the years 2000 and 2001: results of a multi-centric study. Cad Saude Publica. 2007;23(Suppl 3):S379-89.
39. Merçon de Vargas PR. Avoidable infant and perinatal deaths? Lancet. 2000;356(Suppl):s13.
40. Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gülmezoglu AM, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855-61.
41. Miranda AE, Soares RA, Prado BC, Monteiro RB, Figueiredo NC. Mother to child transmission of HIV in Vitória, Brazil: factors associated with lack of HIV prevention. AIDS Care. 2005;17:721-8.
42. Miranda AE, Rosetti Filho E, Trindade CR, Gouvêa GM, Costa DM, Ge Oliveira T, et al. Prevalência de sífilis e HIV utilizando testes rápidos em parturientes atendidas nas maternidades públicas de Vitória, Estado do Espírito Santo. Rev Soc Bras Med Trop. 2009;42:386-91.
43. Mongelli M, Gardosi J. Reduction of false-positive diagnosis of fetal growth restriction by application of customized fetal growth standards. Obstet Gynecol. 1996;88:844-8.
44. Mongelli M, Wilcox M, Gardosi J. Estimating the date of confinement: ultrasonographic biometry versus certain menstrual dates. Am J Obstet Gynecol. 1996;174(1 Pt 1):278-81.
45. Moye J Jr, Rich KC, Kalish LA, Sheon AR, Diaz C, Cooper ER, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr.1996;128:58-69.
46. Ndirangu J, Newell ML, Bland RM, Thorne C. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod. 2012;27:1846-56.
47. Nogueira SA, Abreu T, Oliveira R, Araújo L, Costa T, Andrade M, et al. Successful prevention of HIV transmission from mother to infant in Brazil using a multidisciplinary team approach. Braz J Infect Dis. 2001;5:78-86.
48. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on United States data. Pediatrics. 2010;125:e214-24.
49. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, et al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis. 2010;201:1035-44.
50. Rollins NC, Coovadia HM, Bland RM, Coutsoudis A, Bennish ML, Patel D, et al. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr. 2007;44:321-8.
51. Silveira MF, Santos IS, Barros AJ, Matijasevich A, Barros FC, Victora CG. Increase in preterm births in Brazil: review of population-based studies. Rev Saude Publica. 2008;42:957-64.
52. Szwarcwald CL, Barbosa Júnior A, Souza-Júnior PR, Lemos KR, Frias PG, Luhm KR, et al. HIV testing during pregnancy: use of secondary data to estimate 2006 test coverage and prevalence in Brazil. Braz J Infect Dis. 2008;12:167-72.
53. Townsend CL, Willey BA, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS. 2009;23:519-24.
54. Van der Merwe K, Hoffman R, Black V, Chersich M, Coovadia A, Rees H. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc. 2011;14:42.
55. Villar J, Altman DG, Purwar M, Noble JA, Knight HE, Ruyan P, et al. The objectives, design and implementation of the INTERGROWTH-21st project. BJOG. 2013;120(Suppl 2):9-26. doi:10.1111/1471-0528.12047.
56. Vitória. Estado do Espírito Santo. Secretaria da Saúde. Secretaria de Comunicação. Taxa de mortalidade infantil. [cited 2012 Nov 29]. Available from: http://www.vitoria.es.gov.br/secom.php?pagina=noticias&idNoticia=8098
57. Wigglesworth JS. Perinatal pathology. Philadelphia: W.B. Saunders;1984.
58. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva:WHO; 2000. (Technical Report Series No. 894).
59. Zeitlin JA, Ancel PY, Saurel-Cubizolles MJ, Papiernik E. Are risk factors the same for small for gestational age versus other preterm births? Am J Obstet Gynecol. 2001;185:208-15.